More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months
THURSDAY, Jan. 14, 2021 -- Patients with type 2 diabetes adhering to low-carbohydrate diets (LCDs) for six months may experience greater rates of diabetes remission, according to a review published online Jan. 13 in The BMJ.
Joshua Z. Goldenberg, Ph.D., from Texas A&M University in College Station, and colleagues conducted a systematic review and meta-analysis to examine the efficacy and safety of LCDs and very LCDs (VLCDs) for people with type 2 diabetes. Data were included from 23 trials with 1,357 participants.
The researchers found that compared with control diets, at six months, LCDs achieved higher rates of diabetes remission (defined as hemoglobin A1c [HbA1c] <6.5 percent; 57 versus 31 percent; risk difference, 0.32). When a remission definition of HbA1c <6.5 percent without medication was used, smaller, nonsignificant effect sizes were seen. Data on remission at 12 months were sparse, ranging from a small effect to a trivial increased risk for diabetes. At six months, there were large clinically important improvements in weight loss, triglycerides, and insulin sensitivity, which decreased at 12 months. VLCDs seemed less effective than less restrictive LCDs; this effect was explained by diet adherence. No significant difference was seen in quality of life at six months; however, a clinically important, but not statistically significant, worsening was seen at 12 months.
"Clinicians might consider short term LCDs for management of type 2 diabetes, while actively monitoring and adjusting diabetes medication as needed," the authors write.
One author disclosed financial ties to Texas A&M AgriLife Research.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
FRIDAY, Jan. 15, 2021 -- Dietary fiber intake is inversely associated with depression in premenopausal women, according to a study published online Dec. 21 in Menopause. Yunsun...
WEDNESDAY, Jan. 13, 2021 -- New patient visit volumes decreased across the board at a comprehensive metabolic and weight loss center during the COVID-19 pandemic, but follow-up...
TUESDAY, Jan. 12, 2021 -- From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.